Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Insight Molecular Diagnostics (IMDX) Non-Current Assets (2020 - 2025)

Historic Non-Current Assets for Insight Molecular Diagnostics (IMDX) over the last 6 years, with Q3 2025 value amounting to $6.5 million.

  • Insight Molecular Diagnostics' Non-Current Assets fell 9008.45% to $6.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.5 million, marking a year-over-year decrease of 9749.81%. This contributed to the annual value of $6.3 million for FY2024, which is 1633.55% up from last year.
  • Insight Molecular Diagnostics' Non-Current Assets amounted to $6.5 million in Q3 2025, which was down 9008.45% from $6.7 million recorded in Q2 2025.
  • In the past 5 years, Insight Molecular Diagnostics' Non-Current Assets registered a high of $127.4 million during Q2 2021, and its lowest value of $5.4 million during Q4 2023.
  • Over the past 5 years, Insight Molecular Diagnostics' median Non-Current Assets value was $65.4 million (recorded in 2024), while the average stood at $65.3 million.
  • Its Non-Current Assets has fluctuated over the past 5 years, first surged by 18301.93% in 2021, then crashed by 9270.87% in 2023.
  • Insight Molecular Diagnostics' Non-Current Assets (Quarter) stood at $120.4 million in 2021, then tumbled by 38.09% to $74.6 million in 2022, then tumbled by 92.71% to $5.4 million in 2023, then rose by 16.34% to $6.3 million in 2024, then rose by 2.58% to $6.5 million in 2025.
  • Its Non-Current Assets stands at $6.5 million for Q3 2025, versus $6.7 million for Q2 2025 and $7.2 million for Q1 2025.